These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2225552

  • 1. Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: value of quantitative scoring and approach to final prognosis.
    Alamartine E, Sabatier JC, Berthoux FC.
    Clin Nephrol; 1990 Aug; 34(2):45-51. PubMed ID: 2225552
    [Abstract] [Full Text] [Related]

  • 2. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors.
    Magil AB, Ballon HS, Chan V, Lirenman DS, Rae A, Sutton RA.
    Medicine (Baltimore); 1984 Jul; 63(4):210-20. PubMed ID: 6377004
    [Abstract] [Full Text] [Related]

  • 3. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z, Ji SM, Chen DR, Wen JQ, Chen JS, Liu ZH, Li LS.
    Ren Fail; 2008 Jul; 30(6):611-6. PubMed ID: 18661411
    [Abstract] [Full Text] [Related]

  • 4. IgA nephropathy in Korea: a morphological and clinical study.
    Lee HS, Koh HI, Lee HB, Park HC.
    Clin Nephrol; 1987 Mar; 27(3):131-40. PubMed ID: 3552343
    [Abstract] [Full Text] [Related]

  • 5. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature.
    Ibels LS, Györy AZ.
    Medicine (Baltimore); 1994 Mar; 73(2):79-102. PubMed ID: 8152367
    [Abstract] [Full Text] [Related]

  • 6. Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy.
    Ikee R, Kobayashi S, Saigusa T, Namikoshi T, Yamada M, Hemmi N, Imakiire T, Kikuchi Y, Suzuki S, Miura S.
    Hypertens Res; 2006 Jan; 29(1):15-22. PubMed ID: 16715649
    [Abstract] [Full Text] [Related]

  • 7. [Primary IgA mesangial nephropathy (Berger's disease): clinico-pathological study].
    Nussenzveig I, Saldanha LB, Marcondes M.
    Rev Hosp Clin Fac Med Sao Paulo; 1989 Jan; 44(1):7-20. PubMed ID: 2814190
    [Abstract] [Full Text] [Related]

  • 8. Participation of extracapillary lesions (ECL) in progression of IgA nephropathy.
    Abe T, Kida H, Yoshimura M, Yokoyama H, Koshino Y, Tomosugi N, Hattori N.
    Clin Nephrol; 1986 Jan; 25(1):37-41. PubMed ID: 3955907
    [Abstract] [Full Text] [Related]

  • 9. Factors predicting progression of IgA nephropathies.
    Coppo R, D'Amico G.
    J Nephrol; 2005 Jan; 18(5):503-12. PubMed ID: 16299675
    [Abstract] [Full Text] [Related]

  • 10. A quantitative analysis of the mesangium in children with IgA nephropathy: sequential study.
    Suzuki J, Yoshikawa N, Nakamura H.
    J Pathol; 1990 May; 161(1):57-64. PubMed ID: 2370599
    [Abstract] [Full Text] [Related]

  • 11. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 12. Berger's disease in children. Natural history and outcome.
    Lévy M, Gonzalez-Burchard G, Broyer M, Dommergues JP, Foulard M, Sorez JP, Habib R.
    Medicine (Baltimore); 1985 May; 64(3):157-80. PubMed ID: 3887094
    [Abstract] [Full Text] [Related]

  • 13. Idiopathic IgA mesangial nephropathy. Clinical and histological study of 374 patients.
    D'Amico G, Imbasciati E, Barbiano Di Belgioioso G, Bertoli S, Fogazzi G, Ferrario F, Fellin G, Ragni A, Colasanti G, Minetti L.
    Medicine (Baltimore); 1985 Jan; 64(1):49-60. PubMed ID: 3880853
    [Abstract] [Full Text] [Related]

  • 14. Myofibroblasts, predictors of progression of mesangial IgA nephropathy?
    Goumenos DS, Brown CB, Shortland J, el Nahas AM.
    Nephrol Dial Transplant; 1994 Jan; 9(10):1418-25. PubMed ID: 7816254
    [Abstract] [Full Text] [Related]

  • 15. [Semiquantitative histological evaluation of IgA nephropathy and Cox's proportional Hazzard model analysis].
    Nakao N.
    Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1063-70. PubMed ID: 1808358
    [Abstract] [Full Text] [Related]

  • 16. [IgA nephropathy--analysis of 60 cases].
    Danilewicz M, Wagrowska-Danilewicz M.
    Pol Tyg Lek; 1991 Nov; 49(6-7):141-3. PubMed ID: 8090667
    [Abstract] [Full Text] [Related]

  • 17. Clinical features and natural history of IgA nephropathy.
    Rychlik I, Andrassy K, Waldherr R, Zuna I, Tesar V, Jancová E, Stejskalová A, Ritz E.
    Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
    [Abstract] [Full Text] [Related]

  • 18. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.
    Espinosa M, Ortega R, Gómez-Carrasco JM, López-Rubio F, López-Andreu M, López-Oliva MO, Aljama P.
    Nephrol Dial Transplant; 2009 Mar; 24(3):886-91. PubMed ID: 18842673
    [Abstract] [Full Text] [Related]

  • 19. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

  • 20. [The course and prognosis of mesangioproliferative glomerulonephritis].
    Shilov EM, Tareeva IE, Ivanov AA, Troepol'skaia OV, Krasnova TN, Varshavskiĭ VA, Proskurneva EP, Ivanova LV, Khudova IIu, Miroshnichenko NG.
    Ter Arkh; 2002 Nov; 74(6):11-8. PubMed ID: 12136475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.